Global Lipid Nanoparticles (LNP) Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Lipid Nanoparticles (LNP) market size was valued at US$ 487 million in 2024 and is forecast to a readjusted size of USD 784 million by 2031 with a CAGR of 7.1% during review period.
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
This report is a detailed and comprehensive analysis for global Lipid Nanoparticles (LNP) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipid Nanoparticles (LNP) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid Nanoparticles (LNP)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid Nanoparticles (LNP) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Lipid Nanoparticles (LNP) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lipid Nanoparticles (LNP) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lipid Nanoparticles (LNP), with revenue, gross margin, and global market share of Lipid Nanoparticles (LNP) from 2020 to 2025.
Chapter 3, the Lipid Nanoparticles (LNP) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Lipid Nanoparticles (LNP) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticles (LNP).
Chapter 13, to describe Lipid Nanoparticles (LNP) research findings and conclusion.
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
This report is a detailed and comprehensive analysis for global Lipid Nanoparticles (LNP) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipid Nanoparticles (LNP) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Lipid Nanoparticles (LNP) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid Nanoparticles (LNP)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid Nanoparticles (LNP) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Lipid Nanoparticles (LNP) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- mRNA-lipid Nanoparticle
- siRNA-lipid Nanoparticle
- Others
- Vaccines and Drugs
- Scientific Research
- Precision NanoSystems
- Evonik
- Merck KGaA
- Genevant Sciences
- Exelead
- Avanti Polar Lipids
- Nippon Fine Chemical
- Lipoid
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lipid Nanoparticles (LNP) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lipid Nanoparticles (LNP), with revenue, gross margin, and global market share of Lipid Nanoparticles (LNP) from 2020 to 2025.
Chapter 3, the Lipid Nanoparticles (LNP) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Lipid Nanoparticles (LNP) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticles (LNP).
Chapter 13, to describe Lipid Nanoparticles (LNP) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lipid Nanoparticles (LNP) by Type
1.3.1 Overview: Global Lipid Nanoparticles (LNP) Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Type in 2024
1.3.3 mRNA-lipid Nanoparticle
1.3.4 siRNA-lipid Nanoparticle
1.3.5 Others
1.4 Global Lipid Nanoparticles (LNP) Market by Application
1.4.1 Overview: Global Lipid Nanoparticles (LNP) Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Vaccines and Drugs
1.4.3 Scientific Research
1.5 Global Lipid Nanoparticles (LNP) Market Size & Forecast
1.6 Global Lipid Nanoparticles (LNP) Market Size and Forecast by Region
1.6.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Lipid Nanoparticles (LNP) Market Size by Region, (2020-2031)
1.6.3 North America Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.4 Europe Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.6 South America Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Precision NanoSystems
2.1.1 Precision NanoSystems Details
2.1.2 Precision NanoSystems Major Business
2.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Product and Solutions
2.1.4 Precision NanoSystems Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Precision NanoSystems Recent Developments and Future Plans
2.2 Evonik
2.2.1 Evonik Details
2.2.2 Evonik Major Business
2.2.3 Evonik Lipid Nanoparticles (LNP) Product and Solutions
2.2.4 Evonik Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Evonik Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Lipid Nanoparticles (LNP) Product and Solutions
2.3.4 Merck KGaA Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Genevant Sciences
2.4.1 Genevant Sciences Details
2.4.2 Genevant Sciences Major Business
2.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Product and Solutions
2.4.4 Genevant Sciences Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Genevant Sciences Recent Developments and Future Plans
2.5 Exelead
2.5.1 Exelead Details
2.5.2 Exelead Major Business
2.5.3 Exelead Lipid Nanoparticles (LNP) Product and Solutions
2.5.4 Exelead Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Exelead Recent Developments and Future Plans
2.6 Avanti Polar Lipids
2.6.1 Avanti Polar Lipids Details
2.6.2 Avanti Polar Lipids Major Business
2.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product and Solutions
2.6.4 Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Avanti Polar Lipids Recent Developments and Future Plans
2.7 Nippon Fine Chemical
2.7.1 Nippon Fine Chemical Details
2.7.2 Nippon Fine Chemical Major Business
2.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product and Solutions
2.7.4 Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nippon Fine Chemical Recent Developments and Future Plans
2.8 Lipoid
2.8.1 Lipoid Details
2.8.2 Lipoid Major Business
2.8.3 Lipoid Lipid Nanoparticles (LNP) Product and Solutions
2.8.4 Lipoid Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Lipoid Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lipid Nanoparticles (LNP) Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Lipid Nanoparticles (LNP) by Company Revenue
3.2.2 Top 3 Lipid Nanoparticles (LNP) Players Market Share in 2024
3.2.3 Top 6 Lipid Nanoparticles (LNP) Players Market Share in 2024
3.3 Lipid Nanoparticles (LNP) Market: Overall Company Footprint Analysis
3.3.1 Lipid Nanoparticles (LNP) Market: Region Footprint
3.3.2 Lipid Nanoparticles (LNP) Market: Company Product Type Footprint
3.3.3 Lipid Nanoparticles (LNP) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lipid Nanoparticles (LNP) Consumption Value and Market Share by Type (2020-2025)
4.2 Global Lipid Nanoparticles (LNP) Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2025)
5.2 Global Lipid Nanoparticles (LNP) Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
6.2 North America Lipid Nanoparticles (LNP) Market Size by Application (2020-2031)
6.3 North America Lipid Nanoparticles (LNP) Market Size by Country
6.3.1 North America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
6.3.2 United States Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
6.3.3 Canada Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
6.3.4 Mexico Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
7.2 Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
7.3 Europe Lipid Nanoparticles (LNP) Market Size by Country
7.3.1 Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
7.3.2 Germany Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.3 France Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.5 Russia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.6 Italy Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region
8.3.1 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2031)
8.3.2 China Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.3 Japan Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.4 South Korea Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.5 India Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.7 Australia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
9.2 South America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
9.3 South America Lipid Nanoparticles (LNP) Market Size by Country
9.3.1 South America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
9.3.2 Brazil Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
9.3.3 Argentina Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country
10.3.1 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
10.3.2 Turkey Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10.3.4 UAE Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Lipid Nanoparticles (LNP) Market Drivers
11.2 Lipid Nanoparticles (LNP) Market Restraints
11.3 Lipid Nanoparticles (LNP) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lipid Nanoparticles (LNP) Industry Chain
12.2 Lipid Nanoparticles (LNP) Upstream Analysis
12.3 Lipid Nanoparticles (LNP) Midstream Analysis
12.4 Lipid Nanoparticles (LNP) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Lipid Nanoparticles (LNP) Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Lipid Nanoparticles (LNP) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Lipid Nanoparticles (LNP) Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Precision NanoSystems Company Information, Head Office, and Major Competitors
Table 6. Precision NanoSystems Major Business
Table 7. Precision NanoSystems Lipid Nanoparticles (LNP) Product and Solutions
Table 8. Precision NanoSystems Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Precision NanoSystems Recent Developments andFuture Plans
Table 10. Evonik Company Information, Head Office, and Major Competitors
Table 11. Evonik Major Business
Table 12. Evonik Lipid Nanoparticles (LNP) Product and Solutions
Table 13. Evonik Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Evonik Recent Developments andFuture Plans
Table 15. Merck KGaA Company Information, Head Office, and Major Competitors
Table 16. Merck KGaA Major Business
Table 17. Merck KGaA Lipid Nanoparticles (LNP) Product and Solutions
Table 18. Merck KGaA Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Genevant Sciences Company Information, Head Office, and Major Competitors
Table 20. Genevant Sciences Major Business
Table 21. Genevant Sciences Lipid Nanoparticles (LNP) Product and Solutions
Table 22. Genevant Sciences Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Genevant Sciences Recent Developments andFuture Plans
Table 24. Exelead Company Information, Head Office, and Major Competitors
Table 25. Exelead Major Business
Table 26. Exelead Lipid Nanoparticles (LNP) Product and Solutions
Table 27. Exelead Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Exelead Recent Developments andFuture Plans
Table 29. Avanti Polar Lipids Company Information, Head Office, and Major Competitors
Table 30. Avanti Polar Lipids Major Business
Table 31. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product and Solutions
Table 32. Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Avanti Polar Lipids Recent Developments andFuture Plans
Table 34. NipponFine Chemical Company Information, Head Office, and Major Competitors
Table 35. NipponFine Chemical Major Business
Table 36. NipponFine Chemical Lipid Nanoparticles (LNP) Product and Solutions
Table 37. NipponFine Chemical Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. NipponFine Chemical Recent Developments andFuture Plans
Table 39. Lipoid Company Information, Head Office, and Major Competitors
Table 40. Lipoid Major Business
Table 41. Lipoid Lipid Nanoparticles (LNP) Product and Solutions
Table 42. Lipoid Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Lipoid Recent Developments andFuture Plans
Table 44. Global Lipid Nanoparticles (LNP) Revenue (USD Million) by Players (2020-2025)
Table 45. Global Lipid Nanoparticles (LNP) Revenue Share by Players (2020-2025)
Table 46. Breakdown of Lipid Nanoparticles (LNP) by CompanyType (Tier 1,Tier 2, andTier 3)
Table 47. Market Position of Players in Lipid Nanoparticles (LNP), (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 48. Head Office of Key Lipid Nanoparticles (LNP) Players
Table 49. Lipid Nanoparticles (LNP) Market: Company ProductTypeFootprint
Table 50. Lipid Nanoparticles (LNP) Market: Company Product ApplicationFootprint
Table 51. Lipid Nanoparticles (LNP) New Market Entrants and Barriers to Market Entry
Table 52. Lipid Nanoparticles (LNP) Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Lipid Nanoparticles (LNP) Consumption Value (USD Million) byType (2020-2025)
Table 54. Global Lipid Nanoparticles (LNP) Consumption Value Share byType (2020-2025)
Table 55. Global Lipid Nanoparticles (LNP) Consumption ValueForecast byType (2026-2031)
Table 56. Global Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025)
Table 57. Global Lipid Nanoparticles (LNP) Consumption ValueForecast by Application (2026-2031)
Table 58. North America Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 59. North America Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 60. North America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 61. North America Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 62. North America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 63. North America Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 64. Europe Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 65. Europe Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 66. Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 67. Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 68. Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 69. Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 70. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 71. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 72. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2025) & (USD Million)
Table 75. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2026-2031) & (USD Million)
Table 76. South America Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 77. South America Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 78. South America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 79. South America Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 80. South America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 81. South America Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 82. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 83. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 84. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 85. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 86. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 87. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 88. Global Key Players of Lipid Nanoparticles (LNP) Upstream (Raw Materials)
Table 89. Global Lipid Nanoparticles (LNP)Typical Customers
LIST OFFIGURES
Figure 1. Lipid Nanoparticles (LNP) Picture
Figure 2. Global Lipid Nanoparticles (LNP) Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Lipid Nanoparticles (LNP) Consumption Value Market Share byType in 2024
Figure 4. mRNA-lipid Nanoparticle
Figure 5. siRNA-lipid Nanoparticle
Figure 6. Others
Figure 7. Global Lipid Nanoparticles (LNP) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Lipid Nanoparticles (LNP) Consumption Value Market Share by Application in 2024
Figure 9. Vaccines and Drugs Picture
Figure 10. Scientific Research Picture
Figure 11. Global Lipid Nanoparticles (LNP) Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Lipid Nanoparticles (LNP) Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Market Lipid Nanoparticles (LNP) Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Region in 2024
Figure 16. North America Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 21. CompanyThree Recent Developments andFuture Plans
Figure 22. Global Lipid Nanoparticles (LNP) Revenue Share by Players in 2024
Figure 23. Lipid Nanoparticles (LNP) Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 24. Market Share of Lipid Nanoparticles (LNP) by Player Revenue in 2024
Figure 25.Top 3 Lipid Nanoparticles (LNP) Players Market Share in 2024
Figure 26.Top 6 Lipid Nanoparticles (LNP) Players Market Share in 2024
Figure 27. Global Lipid Nanoparticles (LNP) Consumption Value Share byType (2020-2025)
Figure 28. Global Lipid Nanoparticles (LNP) Market ShareForecast byType (2026-2031)
Figure 29. Global Lipid Nanoparticles (LNP) Consumption Value Share by Application (2020-2025)
Figure 30. Global Lipid Nanoparticles (LNP) Market ShareForecast by Application (2026-2031)
Figure 31. North America Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 32. North America Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 38. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 41.France Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 46. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share by Region (2020-2031)
Figure 48. China Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 51. India Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 55. South America Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 60. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 62.Turkey Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 65. Lipid Nanoparticles (LNP) Market Drivers
Figure 66. Lipid Nanoparticles (LNP) Market Restraints
Figure 67. Lipid Nanoparticles (LNP) MarketTrends
Figure 68. PortersFiveForces Analysis
Figure 69. Lipid Nanoparticles (LNP) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lipid Nanoparticles (LNP) by Type
1.3.1 Overview: Global Lipid Nanoparticles (LNP) Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Type in 2024
1.3.3 mRNA-lipid Nanoparticle
1.3.4 siRNA-lipid Nanoparticle
1.3.5 Others
1.4 Global Lipid Nanoparticles (LNP) Market by Application
1.4.1 Overview: Global Lipid Nanoparticles (LNP) Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Vaccines and Drugs
1.4.3 Scientific Research
1.5 Global Lipid Nanoparticles (LNP) Market Size & Forecast
1.6 Global Lipid Nanoparticles (LNP) Market Size and Forecast by Region
1.6.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Lipid Nanoparticles (LNP) Market Size by Region, (2020-2031)
1.6.3 North America Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.4 Europe Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.6 South America Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Lipid Nanoparticles (LNP) Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Precision NanoSystems
2.1.1 Precision NanoSystems Details
2.1.2 Precision NanoSystems Major Business
2.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Product and Solutions
2.1.4 Precision NanoSystems Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Precision NanoSystems Recent Developments and Future Plans
2.2 Evonik
2.2.1 Evonik Details
2.2.2 Evonik Major Business
2.2.3 Evonik Lipid Nanoparticles (LNP) Product and Solutions
2.2.4 Evonik Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Evonik Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Lipid Nanoparticles (LNP) Product and Solutions
2.3.4 Merck KGaA Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Genevant Sciences
2.4.1 Genevant Sciences Details
2.4.2 Genevant Sciences Major Business
2.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Product and Solutions
2.4.4 Genevant Sciences Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Genevant Sciences Recent Developments and Future Plans
2.5 Exelead
2.5.1 Exelead Details
2.5.2 Exelead Major Business
2.5.3 Exelead Lipid Nanoparticles (LNP) Product and Solutions
2.5.4 Exelead Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Exelead Recent Developments and Future Plans
2.6 Avanti Polar Lipids
2.6.1 Avanti Polar Lipids Details
2.6.2 Avanti Polar Lipids Major Business
2.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product and Solutions
2.6.4 Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Avanti Polar Lipids Recent Developments and Future Plans
2.7 Nippon Fine Chemical
2.7.1 Nippon Fine Chemical Details
2.7.2 Nippon Fine Chemical Major Business
2.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product and Solutions
2.7.4 Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nippon Fine Chemical Recent Developments and Future Plans
2.8 Lipoid
2.8.1 Lipoid Details
2.8.2 Lipoid Major Business
2.8.3 Lipoid Lipid Nanoparticles (LNP) Product and Solutions
2.8.4 Lipoid Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Lipoid Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lipid Nanoparticles (LNP) Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Lipid Nanoparticles (LNP) by Company Revenue
3.2.2 Top 3 Lipid Nanoparticles (LNP) Players Market Share in 2024
3.2.3 Top 6 Lipid Nanoparticles (LNP) Players Market Share in 2024
3.3 Lipid Nanoparticles (LNP) Market: Overall Company Footprint Analysis
3.3.1 Lipid Nanoparticles (LNP) Market: Region Footprint
3.3.2 Lipid Nanoparticles (LNP) Market: Company Product Type Footprint
3.3.3 Lipid Nanoparticles (LNP) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lipid Nanoparticles (LNP) Consumption Value and Market Share by Type (2020-2025)
4.2 Global Lipid Nanoparticles (LNP) Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2025)
5.2 Global Lipid Nanoparticles (LNP) Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
6.2 North America Lipid Nanoparticles (LNP) Market Size by Application (2020-2031)
6.3 North America Lipid Nanoparticles (LNP) Market Size by Country
6.3.1 North America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
6.3.2 United States Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
6.3.3 Canada Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
6.3.4 Mexico Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
7.2 Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
7.3 Europe Lipid Nanoparticles (LNP) Market Size by Country
7.3.1 Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
7.3.2 Germany Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.3 France Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.5 Russia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
7.3.6 Italy Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region
8.3.1 Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2031)
8.3.2 China Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.3 Japan Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.4 South Korea Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.5 India Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
8.3.7 Australia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
9.2 South America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
9.3 South America Lipid Nanoparticles (LNP) Market Size by Country
9.3.1 South America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
9.3.2 Brazil Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
9.3.3 Argentina Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country
10.3.1 Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2031)
10.3.2 Turkey Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
10.3.4 UAE Lipid Nanoparticles (LNP) Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Lipid Nanoparticles (LNP) Market Drivers
11.2 Lipid Nanoparticles (LNP) Market Restraints
11.3 Lipid Nanoparticles (LNP) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lipid Nanoparticles (LNP) Industry Chain
12.2 Lipid Nanoparticles (LNP) Upstream Analysis
12.3 Lipid Nanoparticles (LNP) Midstream Analysis
12.4 Lipid Nanoparticles (LNP) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Lipid Nanoparticles (LNP) Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Lipid Nanoparticles (LNP) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Lipid Nanoparticles (LNP) Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Precision NanoSystems Company Information, Head Office, and Major Competitors
Table 6. Precision NanoSystems Major Business
Table 7. Precision NanoSystems Lipid Nanoparticles (LNP) Product and Solutions
Table 8. Precision NanoSystems Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Precision NanoSystems Recent Developments andFuture Plans
Table 10. Evonik Company Information, Head Office, and Major Competitors
Table 11. Evonik Major Business
Table 12. Evonik Lipid Nanoparticles (LNP) Product and Solutions
Table 13. Evonik Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Evonik Recent Developments andFuture Plans
Table 15. Merck KGaA Company Information, Head Office, and Major Competitors
Table 16. Merck KGaA Major Business
Table 17. Merck KGaA Lipid Nanoparticles (LNP) Product and Solutions
Table 18. Merck KGaA Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Genevant Sciences Company Information, Head Office, and Major Competitors
Table 20. Genevant Sciences Major Business
Table 21. Genevant Sciences Lipid Nanoparticles (LNP) Product and Solutions
Table 22. Genevant Sciences Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Genevant Sciences Recent Developments andFuture Plans
Table 24. Exelead Company Information, Head Office, and Major Competitors
Table 25. Exelead Major Business
Table 26. Exelead Lipid Nanoparticles (LNP) Product and Solutions
Table 27. Exelead Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Exelead Recent Developments andFuture Plans
Table 29. Avanti Polar Lipids Company Information, Head Office, and Major Competitors
Table 30. Avanti Polar Lipids Major Business
Table 31. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product and Solutions
Table 32. Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Avanti Polar Lipids Recent Developments andFuture Plans
Table 34. NipponFine Chemical Company Information, Head Office, and Major Competitors
Table 35. NipponFine Chemical Major Business
Table 36. NipponFine Chemical Lipid Nanoparticles (LNP) Product and Solutions
Table 37. NipponFine Chemical Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. NipponFine Chemical Recent Developments andFuture Plans
Table 39. Lipoid Company Information, Head Office, and Major Competitors
Table 40. Lipoid Major Business
Table 41. Lipoid Lipid Nanoparticles (LNP) Product and Solutions
Table 42. Lipoid Lipid Nanoparticles (LNP) Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Lipoid Recent Developments andFuture Plans
Table 44. Global Lipid Nanoparticles (LNP) Revenue (USD Million) by Players (2020-2025)
Table 45. Global Lipid Nanoparticles (LNP) Revenue Share by Players (2020-2025)
Table 46. Breakdown of Lipid Nanoparticles (LNP) by CompanyType (Tier 1,Tier 2, andTier 3)
Table 47. Market Position of Players in Lipid Nanoparticles (LNP), (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 48. Head Office of Key Lipid Nanoparticles (LNP) Players
Table 49. Lipid Nanoparticles (LNP) Market: Company ProductTypeFootprint
Table 50. Lipid Nanoparticles (LNP) Market: Company Product ApplicationFootprint
Table 51. Lipid Nanoparticles (LNP) New Market Entrants and Barriers to Market Entry
Table 52. Lipid Nanoparticles (LNP) Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Lipid Nanoparticles (LNP) Consumption Value (USD Million) byType (2020-2025)
Table 54. Global Lipid Nanoparticles (LNP) Consumption Value Share byType (2020-2025)
Table 55. Global Lipid Nanoparticles (LNP) Consumption ValueForecast byType (2026-2031)
Table 56. Global Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025)
Table 57. Global Lipid Nanoparticles (LNP) Consumption ValueForecast by Application (2026-2031)
Table 58. North America Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 59. North America Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 60. North America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 61. North America Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 62. North America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 63. North America Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 64. Europe Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 65. Europe Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 66. Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 67. Europe Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 68. Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 69. Europe Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 70. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 71. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 72. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2020-2025) & (USD Million)
Table 75. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value by Region (2026-2031) & (USD Million)
Table 76. South America Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 77. South America Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 78. South America Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 79. South America Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 80. South America Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 81. South America Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 82. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value byType (2020-2025) & (USD Million)
Table 83. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value byType (2026-2031) & (USD Million)
Table 84. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2020-2025) & (USD Million)
Table 85. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Application (2026-2031) & (USD Million)
Table 86. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2020-2025) & (USD Million)
Table 87. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value by Country (2026-2031) & (USD Million)
Table 88. Global Key Players of Lipid Nanoparticles (LNP) Upstream (Raw Materials)
Table 89. Global Lipid Nanoparticles (LNP)Typical Customers
LIST OFFIGURES
Figure 1. Lipid Nanoparticles (LNP) Picture
Figure 2. Global Lipid Nanoparticles (LNP) Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Lipid Nanoparticles (LNP) Consumption Value Market Share byType in 2024
Figure 4. mRNA-lipid Nanoparticle
Figure 5. siRNA-lipid Nanoparticle
Figure 6. Others
Figure 7. Global Lipid Nanoparticles (LNP) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Lipid Nanoparticles (LNP) Consumption Value Market Share by Application in 2024
Figure 9. Vaccines and Drugs Picture
Figure 10. Scientific Research Picture
Figure 11. Global Lipid Nanoparticles (LNP) Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Lipid Nanoparticles (LNP) Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Market Lipid Nanoparticles (LNP) Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Lipid Nanoparticles (LNP) Consumption Value Market Share by Region in 2024
Figure 16. North America Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 21. CompanyThree Recent Developments andFuture Plans
Figure 22. Global Lipid Nanoparticles (LNP) Revenue Share by Players in 2024
Figure 23. Lipid Nanoparticles (LNP) Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 24. Market Share of Lipid Nanoparticles (LNP) by Player Revenue in 2024
Figure 25.Top 3 Lipid Nanoparticles (LNP) Players Market Share in 2024
Figure 26.Top 6 Lipid Nanoparticles (LNP) Players Market Share in 2024
Figure 27. Global Lipid Nanoparticles (LNP) Consumption Value Share byType (2020-2025)
Figure 28. Global Lipid Nanoparticles (LNP) Market ShareForecast byType (2026-2031)
Figure 29. Global Lipid Nanoparticles (LNP) Consumption Value Share by Application (2020-2025)
Figure 30. Global Lipid Nanoparticles (LNP) Market ShareForecast by Application (2026-2031)
Figure 31. North America Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 32. North America Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 38. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 41.France Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 46. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Lipid Nanoparticles (LNP) Consumption Value Market Share by Region (2020-2031)
Figure 48. China Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 51. India Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 55. South America Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share byType (2020-2031)
Figure 60. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Lipid Nanoparticles (LNP) Consumption Value Market Share by Country (2020-2031)
Figure 62.Turkey Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Lipid Nanoparticles (LNP) Consumption Value (2020-2031) & (USD Million)
Figure 65. Lipid Nanoparticles (LNP) Market Drivers
Figure 66. Lipid Nanoparticles (LNP) Market Restraints
Figure 67. Lipid Nanoparticles (LNP) MarketTrends
Figure 68. PortersFiveForces Analysis
Figure 69. Lipid Nanoparticles (LNP) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
